ArticleFrontiers in immunology2025

Efgartigimod combined with rituximab helps improve the symptoms and reduce the use of corticosteroids in patients with MuSK antibody-positive MG: a single case report.

Xiujun Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.